1. Wu M, Ma M, Tan Z,Zheng H(通讯作者), Liu X. Neutrophil: A New Player in Metastatic Cancers. Front.Immunol., 24 September 2020 | https://doi.org/10.3389/fimmu.2020.565165
2. Liu J, Fang Q, Lin H, Yu X,Zheng H(通讯作者), Wan Y. Alginate-poloxamer/silk fibroin hydrogels with covalently [and] physically cross-linked networks f[or] cartilage tissue engineering.Carbohydr Polym. 2020 Nov 1;247:116593.
3.Zheng H, Yu WM, Shen J, Kang S, Hambardzumyan D, Li JY, Shen Y, Kenney AM, Chen J, Qu CK. (2018) Mitochondrial oxidation of the carbohydrate fuel is required f[or] neural precursor/stem cell function [and] postnatal cerebellum development.Sci Adv. 2018 Oct 10;4(10):eaat2681.
4.Zheng H, Yu WM, Waclaw RR, Kontaridis MI, Neel BG, Qu CK. Gain-of-function mutations in the gene encoding the tyrosine phosphatase SHP2 induce hydrocephalus in a catalytically dependent manner.Sci Signal.2018 Mar 20;11(522).
5. Dong L*, Yu WM*,Zheng H*(co-first author), Loh ML, Bunting ST, Pauly M, Huang G, Zhou M, Broxmeyer HE, Scadden DT, Qu CK. Leukemogenic effects of Ptpn11 (Shp2) activating mutations in the stem cell microenvironment.Nature. 2016 Nov 10;539(7628):304-308.
6. Dong L,Zheng H, Qu CK. CCL3 is a key mediat[or] f[or] the leukemogenic effect of Ptpn11-activating mutations in the stem-cell microenvironment.Blood. 2017 Sep 21;130(12):1471-1474.
7. Liu X,Zheng H(co-first author), Li XB, Wang SY, Meyerson HJ, Yang WT, Neel BG, Qu CK. Gain-of-function mutations of Ptpn11 (Shp2) cause aberrant mitosis [and] increase susceptibility to DNA damage-induced malignancies.Proc Natl Acad Sci U S A. 2016 Jan 26;113(4):984-9.
8. Liu X,Zheng H(co-first author), Yu WM, Cooper TM, Bunting KD, Qu CK. Maintenance of hematopoietic stem cells ex vivo by reprogramming cellular metabolism.Blood.2015 125(10):1562-5.
9.Zheng H(corresponding author), Wang SY, Zhou PK, Liu W, Ni F. Effects of Ligustrazine on DNA damage [and] apoptosis induced by irradiation.Environmental Toxicology [and] Pharmacology. 2013, 36: 1197–1206.
10.Zheng H, Li SH, Hsu P, Qu CK. Acute induction of a tumor-associated activating mutation in protein tyrosine phosphatase Ptpn11 (Shp2) leads to cellular senescence [and] apoptosis.J Biol Chem.2013, 288(36): 25727-38.
11. Xu D,Zheng H(co-first author), Yu WM, Qu CK. Activating mutations in protein tyrosine phosphatase Ptpn11 (Shp2) enhance reactive oxygen species production that contributes to myeloproliferative disorder.PLoS ONE. 2013, 8(5): e63152.
12. Liu X,Zheng H, Qu CK. An essential role of protein tyrosine phosphatase Shp2 (Ptpn11) in the maintenance of chromosome stability.Cancer Res.2012, 72 (20):5296-306.
13.Zheng H, Alter S, Qu CK. SHP-2 tyrosine phosphatase in human diseases.Int J Clin Exp Med. 2009, 2(1): 17-25.
14.Zheng H, Zhou PK, Chen ZW, et al. Protective effect of Vanillin derivative dimethoxyvanillin on radiation-induced DNA damage.Eur J Pharm Sci.2008 Jan, 33(1):52-9.
15.Zheng H, Chen XL, Chen ZW, et al. Effect of Ligustrazine on liver injury after burn trauma.Burns.2006, 32:328-34.
16. Gao S, Chen ZW,Zheng H, et al. Ligustrazine attenuates acute myocardium injury after thermal trauma.Burns. 2007, 33(3):321-7.
17.Zheng H, Chen XL, Han ZX, et al, Ligustrazine attenuates acute lung injury after burn trauma.Burns. 2005, 31(4):453-458.